ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_41_length_9993_cov_6.63282_1 # 3 # 143 # 1 # ID=41_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.291	NODE_41_length_9993_cov_6.63282_1 	3	143	+	Strict	400	97.0561	ErmB	100.0	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	CGAGAATATCGTCAACTGTTTACTAAAAATCAGTTTCATCAAGCAATGAAACACGCCAAAGTAAACAATTTAAGTACCATTACTTATGAGCAAGTATTGTCTATTTTTAATAGTTATCTATTATTTAACGGGAGGAAATAA	REYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRK	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	18.55	gnl|BL_ORD_ID|1477|hsp_num:0	1549
NODE_161_length_6076_cov_11.5991_3 # 1214 # 2431 # 1 # ID=161_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_161_length_6076_cov_11.5991_3 	1214	2431	+	Strict	800	780.015	mefA	96.3	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAATACAACAATTGGAAACGAAAATTTTATGCAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCATTAGTAGGTTTTTTACCCTATGCGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCAGTTGCAGCACTCTTATACTCCGTTTGGGATTTAAATGCTATTATTGCCATCGACGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATACCTAAGCTGGGTAATCAAGTGCAAAGTTTAGAACCAAATTTCATAAGGGAGATGAAAGAAGGAGTTGTGGTTCTGAGACAAAACAAAGGATTGTTTGCCTTATTACTCTTAGGAACACTATATACTTTTGTTTATATGCCAATCAATGCACTATTTCCTTTAATAAGCATGGAACACTTTAATGGAACGCCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATTTGGGATGCTAGCAGGAGGCTTATTATTAGGAAGATTAGGGGGCTTCGAAAAGCATGTATTACTAATAACAAGTTCATTTTTTATAATGGGGACCAGTTTAGCCGTTTCGGGAATACTTCCTCCAAATGGATTTGTAATATTCGTAGTTTGCTGTGCAATAATGGGGCTTTCGGTGCCATTTTATAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTGATCGGAAGTATCATGTCACTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAAAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTGGCATTGCTATAGTTTGCCAAATGATAACTGAGGTTAGAAAATTAGATTTAAAATAA	MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAILGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	100.00	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_161_length_6076_cov_11.5991_4 # 2551 # 4014 # 1 # ID=161_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_161_length_6076_cov_11.5991_4	2551	4014	+	Perfect	950	989.178	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAATTAATATTAAAAGCAAAAGACATTCGTGTGGAATTCAAAGGACGCGATGTTTTAGATATAAATGAATTAGAAGTATATGATTATGACCGTATTGGTTTAGTAGGAGCAAATGGTGCTGGAAAAAGCACTTTACTCAGGGTACTTTTAGGAGAATTAACTCCCCCAGGATGTAAAATGAATCGTCTGGGTGAACTTGCCTATATTCCCCAGTTGGACGAAGTAACTCTGCAGGAGGAAAAAGATTTTGCACTTGTAGGCAAGCTAGGTGTTGAGCAATTAAATATACAGACTATGAGCGGTGGTGAAGAAACAAGGCTTAAAATAGCACAGGCCTTATCGGCACAGGTTCATGGTATTTTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAAGGTTCTTCAAAGAAAAAAAGTACTGAAGACGGAGGGCGTTTAGCTCATCAAAAATCAATAGGAAGTAAGGAAAAAAAGATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATGATCTTAAACCATGAAGAAGGAATTTCTATTTCGCCTAAGGCAAAAATAGGTTACTTTGCACAGAATGGTTACAAGTACAACAGTAATCAGAATGTTATGGAGTTTATGCAGAAGGATTGTGACTACAATATATCAGAAATTCGTTCAGTGCTAGCATCTATGGGGTTCAAACAGAACGATATTGGAAAAAGTTTATCTGTTTTAAGCGGTGGAGAAATTATAAAATTGTTGCTTGCTAAAATGCTCATGGGTAGATATAACATCCTAATAATGGATGAACCCAGTAACTTCCTTGACATACCAAGTTTAGAGGCTTTGGAAATACTAATGAAGGAGTACACCGGAACTATCGTGTTTATCACCCACGATAAACGATTACTCGAAAATGTAGCAGATGTAGTTTATGAAATTAGAGATAAGAAAATAAATCTGAAACATTAA	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	100.00	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_228_length_5457_cov_3.64013_3 # 2148 # 2951 # 1 # ID=228_3;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.341	NODE_228_length_5457_cov_3.64013_3	2148	2951	+	Strict	400	530.791	ErmF	98.88	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTATCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGTTAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAG	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.38	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_690_length_3537_cov_6.90063_1 # 1008 # 1973 # 1 # ID=690_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.357	NODE_690_length_3537_cov_6.90063_1	1008	1973	+	Perfect	600	661.374	CfxA3	100.0	3003003	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATTCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTGATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	100.00	gnl|BL_ORD_ID|1813|hsp_num:0	1895
NODE_709_length_3499_cov_6.08449_1 # 1 # 162 # -1 # ID=709_1;partial=10;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.389	NODE_709_length_3499_cov_6.08449_1 	1	162	-	Strict	500	20.4014	OXA-184	100.0	3001476	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAATACACTCGCAGAGAAATTCAGATTGAAAAGAAAAGAGTTGAGACTCTCCCAACAAACTCTTGCAGAAGGAATTTGTGAACAAAGCCAGATTAGTAAAATTGAGAGAGGGCATTTCATTCCCTCAGCAGACCTTTTGTTCAAACTCTCACAACGGCTC	MNTLAEKFRLKRKELRLSQQTLAEGICEQSQISKIERGHFIPSADLLFKLSQRL	MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTFKIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELLEKYIYSLN	21.77	gnl|BL_ORD_ID|1076|hsp_num:0	1126
NODE_1725_length_2375_cov_2.56422_3 # 1049 # 1447 # -1 # ID=1722_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.484	NODE_1725_length_2375_cov_2.56422_3 	1049	1447	-	Loose	1650	25.7942	Streptococcus agalactiae mprF	26.67	3003774	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAAATCCCTTACTCCTCTGCAAAATGCCATTTCCATCATTGGCGGTGTACTTCTTATCATCGGAGCACTCCTTCCGCTTGCTGGAGTCTTGGCACAATATGCTCCTTATGTCTTCGCTCTGGGAGCACTCTCTTATGGCGGCACGCAGATTTTGCGCCGTTATGAAGGCAAAAACACCACGATTATCCGACTGCGTCGTCAAGAAATTATCAGTGCTTTCCTTTTGATGGTTAGTGCAGTGCTGATGCTCGTGAGCAGTTTTCGCTTGTTGCCTTTGCAAGGTGGGGAGTGGAAGCTCTGTCTTGCCGTAGCTGTCGTGTTTCAATTATACACCGCCTTCCGTCTTCCCCAAGAGTTGGACAAAGAAGCGCGTCAAAAGGAGCAGAAAAACGGATAA	MKSLTPLQNAISIIGGVLLIIGALLPLAGVLAQYAPYVFALGALSYGGTQILRRYEGKNTTIIRLRRQEIISAFLLMVSAVLMLVSSFRLLPLQGGEWKLCLAVAVVFQLYTAFRLPQELDKEARQKEQKNG	MLKKLIEKVKSLTSVIKIVFFISVLVLIIVEMIHLKRTISVEQLKSVFGQLSPMNLFLIILVGVIAVLPTTGYDFVLNGLLRTDKSKRYILQTSWCINTFNNLSGFGGLIDIGLRMAFYGKKGQEKSDLREVTRFLPYLISGLSFISVIALIMSHIFHAKASVDYYYLVLIGASMYFPVIYWISGHKGSHYFGDMPSSTRIKLGVVSFFEWGCAAAAFIIIGYLMGIHLPVYKILPLFCIGCAVGIVSLIPGGLGSFELVLFTGFAAEGLPKETVVAWLLLYRLAYYIIPFFAGIYFFIHYLGSQINQRYENVPKELVSTVLQTMVSHLMRILGAFLIFSTAFFENITYIMWLQKLGLDPLQEQMLWQFPGLLLGVCFILLARTIDQKVKNAFPIAIIWITLTLFYLNLGHISWRLSFWFILLLLGLLVIKPTLYKKQFIYSWEERIKDGIIIVSLMGVLFYIAGLLFPIRAHITGGSIERLHYIIAWEPIALATLILTLVYLCLVKILQGKSCQIGDVFNVDRYKKLLQAYGGSSDSGLAFLNDKRLYWYQKNGEDCVAFQFVIVNNKCLIMGEPAGDDTYIREAIESFIDDADKLDYDLVFYSIGQKLTLLLHEYGFDFMKVGEDALVNLETFTLKGNKYKPFRNALNRVEKDGFYFEVVQSPHSQELLNSLEEISNTWLEGRPEKGFSLGYFNKDYFQQAPIALVKNAEHEVVAFANIMPNYEKSIISIDLMRHDKQKIPNGVMDFLFLSLFSYYQEKGYHYFDLGMAPLSGVGRVETSFAKERMAYLVYHFGSHFYSFNGLHKYKKKFTPLWSERYISCSRSSWLICAICALLMEDSKIKIVK	15.58	gnl|BL_ORD_ID|2132|hsp_num:0	2283
NODE_2118_length_2169_cov_4.61211_3 # 1599 # 1838 # 1 # ID=2109_3;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.287	NODE_2118_length_2169_cov_4.61211_3 	1599	1838	+	Loose	400	23.483	ErmQ	30.77	3000593	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAAAAAAAGTCTATACAATCTATTGTCAATGATTCCAATATATGGAACATTTTTAAAATTTTCAAGTAAAGGTGAAATGAGGTTATGTAGCTTACTGTATCAAGATTTATTAGATGAAGGGATTAATCCAAATGATATATTCTTACTTCTTGAAAAAAAATATCCTGGTGAAGTAGTTACAAGAGACCGTTTCTACGAAGGTTATGGAGAAATACTGGAATCTTTGAACAAAGAGTAA	MKKSLYNLLSMIPIYGTFLKFSSKGEMRLCSLLYQDLLDEGINPNDIFLLLEKKYPGEVVTRDRFYEGYGEILESLNKE	MKAKSNNYRGKVDISVSQNFITSKNTIYKLIKKTNISKNDFVIEIGPGKGHITEALCEKSYWVTAIELDRSLYGNLINKFKSKNNVTLINKDFLNWKLPKKREYKVFSNIPFYITTKIIKKLLLEELNSPTDMWLVMEKGSAKRFMGIPRESKLSLLLKTKFDIKIVHYFNREDFHPMPSVDCVLVYFKRKYKYDISKDEWNEYTSFISKSINNLRDVFTKNQIHAVIKYLGINLNNISEVSYNDWIQLFRYKQKID	30.74	gnl|BL_ORD_ID|284|hsp_num:0	303
NODE_2181_length_2135_cov_2.55865_3 # 2033 # 2134 # -1 # ID=2172_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.422	NODE_2181_length_2135_cov_2.55865_3 	2033	2134	-	Loose	1800	20.4014	MexD	34.62	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	CCTGCAGAGGCTTTGGCTCGCTTTATGGATTATATTGATGGCGCATTGCTCGTGGTCACAACGCAACATTCGACTATCAAATTCTCTATAACAACCTTTTAA	PAEALARFMDYIDGALLVVTTQHSTIKFSITTF	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	3.16	gnl|BL_ORD_ID|1546|hsp_num:0	1523
NODE_2350_length_2072_cov_4.69162_1 # 2 # 103 # -1 # ID=2340_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.627	NODE_2350_length_2072_cov_4.69162_1 	2	103	-	Loose	600	20.0162	TLA-2	50.0	3003203	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; cephalosporin	antibiotic inactivation	TLA beta-lactamase	ATGGCTGAGGCGAAGTATAAGCATCTCGTATTCGGGACGGTAATCACCAGTGAGGAAGAGCCGCCCGGCCCGTGGGAGCCGCACACTGACGCCAAGCCCGCC	MAEAKYKHLVFGTVITSEEEPPGPWEPHTDAKPA	MNIKYFKFAEKFILLVLIMSFSSLAFCKSDDSLEQRINSIISGKKASVGVAVAGIEDNFSLSINGKKNFPMMSVYKLHIVLAVLNKVDGGSLKLDEKIPLNKKDLHPGTWSPLRDKYPNGGVSIPLSEIIEYTITQSDNNGCDILIALAGGTEAVKRYIISKGISDFDIRATEKECHESWNVQYSNWSTPVSAVALLKKFNDRKILSSVSTEYLMNVMIHTSTGNKRIKGLIPPSADVAHKTGTSGIRNGITPGTNDIGIVTLPNGKHFAIAVFVSDSRENNAANERIIAEISKAAWDYFVKMN	11.18	gnl|BL_ORD_ID|90|hsp_num:0	102
NODE_2736_length_1922_cov_9.81735_3 # 1770 # 1922 # 1 # ID=2717_3;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.379	NODE_2736_length_1922_cov_9.81735_3 	1770	1922	+	Strict	1300	21.9422	vanTE	100.0	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGGCAGCTCAAACTCAACAATTAACACCAGAATTAACTTTAGAATATATCAATGAAATTCCTGTTTTAATCTTAAATCACCCAGTAGGATCGGCTCGAATTGCATTACAAGGGGCGCAATTATTAAATTGGCAACCTAAAGGGGCAGAGCAG	MAAQTQQLTPELTLEYINEIPVLILNHPVGSARIALQGAQLLNWQPKGAEQ	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	7.26	gnl|BL_ORD_ID|1251|hsp_num:0	1308
NODE_4582_length_1491_cov_17.6539_1 # 3 # 104 # -1 # ID=4496_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.382	NODE_4582_length_1491_cov_17.6539_1 	3	104	-	Strict	500	18.8606	OXA-54	100.0	3001812	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACAGAGCAAAACAAACAAAAAGGCTTGGAATGGCAAGAGAAACCGCTTTCTGACAATGAACGCTTAAAAACCGACAGTAACTTTTTACGCGGTACGATT	MTEQNKQKGLEWQEKPLSDNERLKTDSNFLRGTI	MRVLALSAVLVVASIVGMPAMANEWQEKPSWNTHFSEHKAQGVIVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQIGQARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATEQVAFLRKLYHNKLHVSERSQRIVKQAMLTEANSDYIIRAKTGYSTRIEPQIGWWVGWVELDDNVWFFAMNMDMPTADGLGLRQAITKEVLKQEKIIP	12.83	gnl|BL_ORD_ID|412|hsp_num:0	441
NODE_5584_length_1348_cov_4.30549_1 # 3 # 86 # 1 # ID=5445_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.536	NODE_5584_length_1348_cov_4.30549_1 	3	86	+	Loose	400	20.0162	catD	53.85	3002682	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ACCGCCAAAATACGCGGCGGCGAAGTGATTGAGTTTGACGGTGCGCGCTTGGAAATCGCCGATGGATACGACCCTGAAGAATAA	TAKIRGGEVIEFDGARLEIADGYDPEE	MVFEKIDKNSWNRKEYFDHYFASVPCTYSMTVKVDITQIKEKGMKLYPAMLYYIAMIVNRHSEFRTAINQDGELGIYDEMIPSYTIFHNDTETFSSLWTECKSDFKSFLADYESDTQRYGNNHRMEGKPNAPENIFNVSMIPWSTFDGFNLNLQKGYDYLIPIFTMGKYYKEDNKIILPLAIQVHHAVCDGFHICRFVNELQELINS	13.04	gnl|BL_ORD_ID|1496|hsp_num:0	1569
NODE_6171_length_1273_cov_6.58292_2 # 500 # 1273 # 1 # ID=5989_2;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.420	NODE_6171_length_1273_cov_6.58292_2 	500	1273	+	Strict	750	496.123	pmrA	97.67	3000822	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACAGAGATTAGCTGGAAGGATAATCTGCGCATTGCCTGGTTTGGTAATTTTCTGACAGGAGCCAGTATTTCCTTAGTTGTGCCTTTTATGCCCATCTTTGTGGAAAATCTAGGTGTAGGGAGTGATCAAGCTGCTTTTTATGCAGGTTTAGCTATTTCTGTCTCTGCTATTTCCGCGGCACTTTTCTCTCCTATCTGGGGCATCCTTGCTGATAAATACGGTCGAAAACCCATGATGATTCGGGCTGGCCTGGCCATGACTATTACTATGGGAGGCTTGGCCTTTGTGCCAAATATTTATTGGTTAATCTTTCTTCGTTTATTAAACGGTGTGTTTGCAGGATTTGTTCCCAATGCAACAGCCTTGATAGCCAGTCAGGTTCCCAAGGAGAAATCAGGCTCTGCCTTAGGTACTTTGTCTACAGGCGTAGTTGCAGGCACTCTAACTGGTCCCTTTATTGGTGGCTTTATCGCAGAATTATTTGGCATTCGTACTGTCTTTTTACTGGTGGGTAGTTTTCTATTTTTAGCTGCTATTTTGACTATTTTATTTATTAAGGAAGATTTTCAACCAGTAGCCAAGGAAAAGGCCATCCCAACAAAGGAATTATTTACATCAGTTAAATATCCCTATCTTTTGCTCAACCTCTTTCTGACCAGTTTTGTCATCCAATTTTCAGCCCAATCAATCGGTCCTATCTTAGTTCTGTATGTGCGCGACTTAGGCCAGGCAGAGAATCTTCTCTTTGTCTCTGGTTTGATTGTATCCAGT	MTEISWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSDQAAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTILFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILVLYVRDLGQAENLLFVSGLIVSS	MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISAALFSPIWGILADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPKEKSGSALGTLSTGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIPTKELFTSVKYPYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVMGKLGDKVGNHRLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRVFAFNQVFFYLGGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI	64.66	gnl|BL_ORD_ID|2000|hsp_num:0	2003
NODE_7585_length_1138_cov_2.22899_1 # 1 # 1137 # -1 # ID=7266_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.398	NODE_7585_length_1138_cov_2.22899_1 	1	1137	-	Loose	700	24.6386	DHA-3	28.75	3002134	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	GGTACAAACACCAATAAACAGAATGCTGTTGGCCAAGAAAACAACGACACTACAGACGTTATTGATATGGACTCGCCTACTGATTCCGTTCCTAATATGAGCGATTCGAGCGACCCTCACAAGCGAAGTTACTATCTTGCGCAAATTCCTTTCACGCCAGAACAACTCAAAGAAAGCAATGACAAGCTAAGCAACGCATTGTATCAGTCTGCGGTTATCTTTAAAGATGAATTGGATAACCTACGTTTAAGCGAGCGCAACTTTATGCGTTTAGAAACCCAATTCCCTGGAAATAGCCACGAGGCAGAGGCTTATTACCATCTATATTTATTATATTCACGCTACAAAAACACGGCAAAAGCCAATCATTATCTTGCTCTTTTAAAGGATAAGTATCCTAAAAACGAGCTAACAAACATCTTAACCGATCCTTATTTCGTGCAAGATGCGCAAAATGGAAAGCACTTTGAAGACTCATTATATACCGAAACATACGAGGCTTTCAAAGCAAATGATATCTATAAGGTTAGAAACAATCTTGCGATATCAACCAAACGTTTCCCAAAAGGCGCCAATAGAGATAAGTTTTTGTTTATCGGTGCGCTTGGAAAGTTAAACAATGGAGAGCCTAAAGAGTGCTTAGAAGACTTGGAGAACATTGTTACCAACTTCCCAAATAGTAAGCTCAACCACCTTGCAGGCAATATTATTAATGGCGTAAAAGCAGGTAGAAAGCTTCAAGGAGGTAAGTTTGATATGTCTAAGATGTGGAATCAAAGAAGCGAAGTGTTGAACAACACAGACTCAACCGCTGTTAAATCGTTTACCAACGACACCAATATTCCATTCATGGTGTTGATGGTTTACAACCCCGATTCTATCGATAAGAACAAACTTTTATATGCCATTGCGAAATACAACTTCACAGGTTTCCCTGTAAGAAGTTTTGACATCGACACCCAAAGCTCACCCAATGGCGAGGAAATGCAGATTGGAGGCTTCAATAATTTCGATGAAGCGTTGCTCTATGCTCGTAAGATTAGACAACAACGAGATATCATTCGCTTGCTCAGTAAGGCGCACATATATGTCATCAGCAATAAAAATGCTGAGCTACTACATAGCGGTTTGGGTTAT	GTNTNKQNAVGQENNDTTDVIDMDSPTDSVPNMSDSSDPHKRSYYLAQIPFTPEQLKESNDKLSNALYQSAVIFKDELDNLRLSERNFMRLETQFPGNSHEAEAYYHLYLLYSRYKNTAKANHYLALLKDKYPKNELTNILTDPYFVQDAQNGKHFEDSLYTETYEAFKANDIYKVRNNLAISTKRFPKGANRDKFLFIGALGKLNNGEPKECLEDLENIVTNFPNSKLNHLAGNIINGVKAGRKLQGGKFDMSKMWNQRSEVLNNTDSTAVKSFTNDTNIPFMVLMVYNPDSIDKNKLLYAIAKYNFTGFPVRSFDIDTQSSPNGEEMQIGGFNNFDEALLYARKIRQQRDIIRLLSKAHIYVISNKNAELLHSGLGY	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPDSAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNIEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	100.00	gnl|BL_ORD_ID|1926|hsp_num:0	2015
NODE_7653_length_1131_cov_2.71097_1 # 2 # 1114 # 1 # ID=7326_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.406	NODE_7653_length_1131_cov_2.71097_1 	2	1114	+	Strict	1200	761.14	tetO	99.19	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATATATAGCGGAACATTGCATTTGAGGGATGTTATTAGAATATCTGAAAAAGAGAAAATAAAAATCACAGAGATGTGTGTTCCGACAAACGGTGAATTATATTCATCCGATACAGCCTGCTCTGGTGATATTGTAATTTTACCAAATGATGTTTTGCAGCTAAACAGTATTTTGGGGAACGAAATACTGTTGCCGCAGAGAAAATTTATTGAAAATCCTCTCCCTATGCTCCAAACAACGATTGCAGTAAAGAAATCTGAACAGCGGGAAATATTGCTTGGGGCACTTACAGAAATTTCAGATGGCGACCCTCTTTTAAAATATTATGTGGATACTACAACGCATGAGATTATACTTTCTTTTTTGGGGAATGTGCAGATGGAAGTCATTTGTGCCATCCTTGAGGAAAAATATCATGTGGAGGCAGAAATAAAAGAGCCTACTGTTATATATATGGAAAGACCGCTTAGAAAAGCAGAATATACCATCCACATAGAAGTCCCGCCAAATCCTTTCTGGGCTTCTGTCGGGTTGTCCATAGAGCCGCTCCCTATTGGAAGCGGAGTGCAGTATGAAAGCAGAGTTTCACTTGGATATTTAAATCAATCGTTCCAAAATGCGGTTATGGAGGGGGTTCTTTATGGCTGCGAGCAGGGGCTGTATGGATGGAAAGTGACAGACTGTAAAATCTGTTTTGAATATGGATTGTATTATAGTCCTGTAAGTACCCCCGCAGACTTTCGGCTGCTTTCCCCTATCGTATTGGAGCAGGCTTTAAAAAAAGCAGGGACAGAACTATTAGAGCCATATCTCCACTTTGAAATTTATGCACCGCAGGAATATCTCTCACGGGCGTATCATGATGCTCCAAGGTATTGTGCAGATATTGTAAGTACTCAGATAAAGAATGACGAGGTCATTCTGAAAGGAGAAATCCCTGCTAGATGTATTCAAGAATACAGGAACGATTTAACTTATTTCACAAATGGGCAGGGAGTCTGCTTGACAGAGTTAAAAGGATACCAGCCAGCTATTGGTAAATTTATTTGCCAACCCCGCCGCCCGAATAGCCGTATAGATAAGGTTCGGCATATGTTCCACAAGTTAGCTTAA	IYSGTLHLRDVIRISEKEKIKITEMCVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMLQTTIAVKKSEQREILLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	57.90	gnl|BL_ORD_ID|1931|hsp_num:0	2020
NODE_8365_length_1073_cov_16.0688_1 # 3 # 104 # 1 # ID=7948_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.431	NODE_8365_length_1073_cov_16.0688_1 	3	104	+	Loose	600	21.9422	vanHB	50.0	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATTGAAAACGACAAGTACAATCCAACCCTGGAACTCTGTCTCAATCTCGCCCGTAGCCTCCAAACTGACCTCAACAGTCTCTTTTGGGAGGATAATTTTTAA	IENDKYNPTLELCLNLARSLQTDLNSLFWEDNF	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	10.22	gnl|BL_ORD_ID|590|hsp_num:0	626
NODE_9174_length_1016_cov_4.42768_2 # 203 # 1015 # 1 # ID=8650_2;partial=01;start_type=ATG;rbs_motif=AAAA;rbs_spacer=4bp;gc_cont=0.399	NODE_9174_length_1016_cov_4.42768_2 	203	1015	+	Strict	1200	558.14	tetO	99.26	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATTAACTTAGGCATTCTGGCTCACGTTGACGCAGGAAAGACAACATTAACGGAAAGTTTATTGTATACCAGTGGTGCAATTGCAGAACTAGGGAGCGTAGATGAAGGCACAACAAGGACAGATACAATGAATTTGGAGCGTCAAAGGGGAATCACTATCCAGACAGCAGTGACATCTTTTCAGTGGGAGGATGTAAAAGTCAACATTATAGATACGCCAGGCCATATGGATTTTTTGGCGGAAGTATACCGTTCTTTATCCGTATTAGACGGAGCAGTATTATTAGTTTCTGCAAAGGATGGCATACAGGCACAGACCCGTATACTGTTTCATGCACTACAGATAATGAAGATTCCGACAATTTTTTTCATCAATAAAATTGACCAAGAGGGGATTGATTTGCCAATGGTATATCGGGAAATGAAAGCAAAGCTTTCTTCGGAAATTATAGTGAAGCAAAAGGTTGGGCAGCATCCCCATATAAATGCAACGGACAATGACGATATGGAACAGTGGGATGCGGTAATTATGGGAAACGATGAACTATTAGAGAAATATATGTCAGGGAAACCGTTTAAAATGTCAGAACTGGAACAGGAAGAAAACAGGAGATTCCAAAACGGAACGTTATTTCCCGTTTATCACGGAAGCGCTAAAAACAATCTGGGGATTCGGCAGCTTATAGAAGTAATTGCCAGTAAATTTTATTCATCAACGCCTGAAGGTCAATCTGAACTATGCGGGCAGGTTTTTAAGATTGAATATTCAGAGAAAAGGCGGCGTTTTGTTTATGTGCGTATATAT	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINATDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIY	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	42.41	gnl|BL_ORD_ID|1931|hsp_num:0	2020
NODE_9345_length_1005_cov_12.92_2 # 853 # 1005 # 1 # ID=8790_2;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.386	NODE_9345_length_1005_cov_12.92_2 	853	1005	+	Loose	200	23.483	ANT(3'')-IIb	50.0	3004090	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGACAGCTCAAACTCAACAATTAACACCAGAATTAACGTTAGAACATATCAATGAAATTCCTGTTTTAACCTTAAATCACCCTGTAGGTTCCGCTCAAATTGCATTACAAGGGGCGCAATTATTAAATTGGCAACCTAAAGGGGCAGAGCAG	MTAQTQQLTPELTLEHINEIPVLTLNHPVGSAQIALQGAQLLNWQPKGAEQ	MSEQFQLQQLQEYLHALFAESLFAIYLYGSAVDGGLGPESDLDLLVVVTQPLTHVQRQQLAQALLTLSHPIGGLQRALEVTILLKEEVISGRYPLNYELQFGEWLREELVDGGELSAQNDPDISILLKKAHMHHRTLFGPDLTSWLDEIPDQQLWQAMADLYPSIVAHWDEDGDERNQILALCRIYFSLSLGEIVSKSHAAQWVIAQLEEKDQPVLQRMVQEYKGEMTKQDWPSQHQVLQPIVNFLSQHIETFFDKKGLKIKQ	19.39	gnl|BL_ORD_ID|2303|hsp_num:0	2754
NODE_9491_length_996_cov_2.49734_1 # 1 # 558 # 1 # ID=8915_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.513	NODE_9491_length_996_cov_2.49734_1 	1	558	+	Loose	650	82.4185	mexP	34.38	3003698	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; acridine dye; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TACTTCTCGATGACGGAAAAACAACTCCTCGAGATGACGCGTACCACCGGCGGAGTTGAAGCCGCCATTCGTGAGATGCCCGCGGTTTCGCTCGTCTTGGCAGACGGAACCACCTACGATCGCAAAGGAAAGGTCAGCGCCGTATCCGGTGTGGCCGATGTAGGCACGGGAAGTGTGAAGATGCGCGCCACCTTCGACAACCCCCATCAAGTACTCCGCTCCGGAACGACGGGACAAGTCAGCTTCCCGGTGAATAAGAGCAATGCGATTCTCGTTCAACAGAAGAGTACGGTTGAAATCCAGAATAAGAAGTTTGTCTATGTTGTGGACAAGAACAACAAAGTGCACTCCACCGAGATCGAAGTACTCGCCCAAAACGACGGACAAAACTATGTCGTGACGAAAGGCCTCAGTGTAGGTGACCGCATTGTCGTAGAAGGAGTGAACAAACTCAAGAACGACATGGAAATTAAGCCCATCACACCCGAACAGAGTGCCAAACAACTCGAAAAGTCGATGGATCACATGGCAAAGAAGAAAATGCCCGGACAAGAGTAA	YFSMTEKQLLEMTRTTGGVEAAIREMPAVSLVLADGTTYDRKGKVSAVSGVADVGTGSVKMRATFDNPHQVLRSGTTGQVSFPVNKSNAILVQQKSTVEIQNKKFVYVVDKNNKVHSTEIEVLAQNDGQNYVVTKGLSVGDRIVVEGVNKLKNDMEIKPITPEQSAKQLEKSMDHMAKKKMPGQE	MNLRHFIRITATLGVAALIAGCGESAPPGAASAPPSVPVAEVVVRPVTPYAEFTGSLTAVEQVELRPRVAGYIQDVTVPEGRLVEKGQQLFLIDPRVFKAAQDAARARLREAEAAALLARTEHERAELLYARKVVARERLDSAIASRNASKAQVDAARAALDAAQLDLGFTRVTAPIGGRVGHIQVTEGNYVTNGVTALTSIVSVDPLYVYFDVDERTYLQALAPTRGREGEQAPRVKVALLTDESYGRSSRLDFLANAADRGTGTVRVRAVVDNPDGQLTPGLFAKVRLETGKPRAQVLVADHSIGTDQGRRYVLVVDEGNKTQYRPVELGPMVDGLRVVRQGLQPGERIVVKGLVRPDMQITPRLAEIDGTPVDLSKTVGAAQ	48.05	gnl|BL_ORD_ID|2076|hsp_num:0	2211
NODE_10329_length_949_cov_2.78635_1 # 1 # 339 # 1 # ID=9614_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.369	NODE_10329_length_949_cov_2.78635_1 	1	339	+	Strict	1200	236.113	tetQ	100.0	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	CAACAGTCAGGTGTGGACATTCTCGAACCGATGCTCTATTTTGAGTTGCAGATACCCCAAGCGGCAAGTTCCAAAGCTATTACAGATTTGCAAAAAATGATGTCTGAGATTGAAGACATCAGTTGCAATAATGAGTGGTGTCATATTAAAGGGAAAGTTCCATTAAATACAAGTAAAGACTACGCCTCAGAAGTAAGTTCATACACTAAGGGCTTAGGCGTTTTTATGGTCAAGCCATGCGGGTATCAAATAACAAAAGGCGATTATTCTGATAATATCCGCATGAACGAAAAAGATAAACTTTTATTCATGTTCCAAAAATCAATGTCATCAAAATAA	QQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	17.05	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_10709_length_929_cov_3.28032_3 # 773 # 928 # 1 # ID=9930_3;partial=01;start_type=ATG;rbs_motif=TAA;rbs_spacer=14bp;gc_cont=0.532	NODE_10709_length_929_cov_3.28032_3 	773	928	+	Loose	400	21.1718	DIM-1	33.33	3000848	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	DIM beta-lactamase	ATGTTGATTGCTTTTTTGATTATGTTGCGCGAGGGTATCGAGGCGGCTTTGATCGTCGGTATCGTCGCGGGTTTTTTGAAACAGTCGGGACATTCGCGGCTGATGCCTAAGGTGTGGCTGGGCGTGGCTTTGGCTGCGCTGATGTGTTTGGGCATC	MLIAFLIMLREGIEAALIVGIVAGFLKQSGHSRLMPKVWLGVALAALMCLGI	MRTHFTALLLLFSLSSLANDEVPELRIEKVKENIFLHTSYSRVNGFGLVSSNGLVVIDKGNAFIVDTPWSDRDTETLVHWIRKNGYELLGSVSTHWHEDRTAGIKWLNDQSISTYATTSTNHLLKENKKEPAKYTLKGNESTLVDGLIEVFYPGGGHTIDNVVVWLPKSKILFGGCFVRSLDSEGLGYTGEAHIDQWSRSAQNALSRYSEAQIVIPGHGKIGDIALLKHTKSLAETASNKSIQPNANASAD	20.72	gnl|BL_ORD_ID|1702|hsp_num:0	1718
NODE_10906_length_919_cov_3.84259_1 # 1 # 315 # 1 # ID=10089_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.413	NODE_10906_length_919_cov_3.84259_1 	1	315	+	Loose	350	26.5646	cat	30.12	3002670	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	CAGAAACAACGTTGGTTTTTATTGCAACTGGTTGGCGATGCCAAGAATATCAATATGCAATGCAGCAAAACGCCGGAGTTTGACGGATGGCGTTGGGTGAGTTTTTGGTATCCGGTGCGTCAAGTGGTGTCTTTTAAAAAAGAGGTTTATCGTAAAGCCATGAAAGAGTTTGCTGCGGTGTTATTTGATGAAAATAATAAAGCGTTGTTGCATAGCGAAACAGAGACTTACGACGAAAAGAAATCTACCTTCTCATCTCATAAACAACATTATTCCAAACAGCCGAAACGCGCGCCGCACAAATACAAAGGATAA	QKQRWFLLQLVGDAKNINMQCSKTPEFDGWRWVSFWYPVRQVVSFKKEVYRKAMKEFAAVLFDENNKALLHSETETYDEKKSTFSSHKQHYSKQPKRAPHKYKG	MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKHAEFRMAMKDGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTYSEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK	47.93	gnl|BL_ORD_ID|782|hsp_num:0	823
NODE_13656_length_805_cov_2.23733_2 # 689 # 805 # 1 # ID=12245_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.470	NODE_13656_length_805_cov_2.23733_2 	689	805	+	Loose	500	21.9422	OXA-258	42.86	3001503	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGATCCAAAAGAGTTAGTGTGTTTGCAAGGAGCGTACGCAGTTGAAAAAGGGGTACATCAAGTTAATAGCGGCCATCGTACTCGGTGCGGCTATTATCGGTGGTGGGATTTATGG	MDPKELVCLQGAYAVEKGVHQVNSGHRTRCGYYRWWDLW	MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPVKAAAYDLAENLFEVGEADGWRLYGKTGTGSPGSHGVYTPANAYGWFVGWARKDDRQLVFARLLQDEGATQPNAGLRARDGLMRDWAAMVAAPRK	14.23	gnl|BL_ORD_ID|1587|hsp_num:0	1659
NODE_13733_length_802_cov_2.87416_2 # 711 # 800 # -1 # ID=12303_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.367	NODE_13733_length_802_cov_2.87416_2 	711	800	-	Loose	1200	19.631	LRA-13	85.71	3002484	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase; class D LRA beta-lactamase	GCTCGCCAATTAGGCATGCATCATACTGGTACAGCTAAAGTAAAATTAGCAGTATTGAATAAAAACAAAAGAGAACTGGAAGACAGTTAA	ARQLGMHHTGTAKVKLAVLNKNKRELEDS	MNFRHIVMAALCGLAWTPAIHATEVCIAIAEAGTGAVLVQRGDCQRQVTPASTFKIAISLMGYDSGFLKDAHAPKLPFRPGYVDWRPSWREPTDPAKWMSDSVVWYSQQVTKSLGMQRFADYTRNFKYGNADVSGDAENDGLSMSWISSSLRISPLEQLAFLDKIVNRRLGVSAHAYDMTAQLTKFDQPPAGWRINGKTGAASGYGWYVGWASKGSRTFVFAHLMQRDATQPQDVSAGVLARDEFLKELPGLMIKDMVDRAVQPLMKKYDIPGMAVAVTDNGKNYFFNYGLASRETGQAVTSHTLFEIGSLSKTMAATLTSYAQVNGQLALTDTVSRHMPKLRGGGFDKISLLNLGTHTAGDFPMQVPDHIETYEQLMEYYKNWKPGVAAGGARTYSNLTVGLLGIITAQSMGMPFAEAMENRLFPQLGMHHSYINVPAAEMKNYAQGYNQANAPVRINPAVLATEAYGVKTDAADLIRFVDANMGLVKLDEKLQRAVTGTHTAYFKTGELTQDLIWEQYPAASKLDRMLAGVSEKMVFESNPATRLAPPMPPQADVLINKTGSTGGFGAYALFNPGKKTGIVMLANKSYPGAERVTAAWHILDQLDQR	4.76	gnl|BL_ORD_ID|1829|hsp_num:0	1912
NODE_16318_length_719_cov_3.91717_3 # 636 # 719 # 1 # ID=14206_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.417	NODE_16318_length_719_cov_3.91717_3 	636	719	+	Loose	650	19.631	adeL	66.67	3000620	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTGATGATTATTGCGCGTTTGCATGCTATAGTGGATTAAATTTAAATCAGGACAAGGCGACGAAGCCGCAGACAGTACAG	MFDDYCAFACYSGLNLNQDKATKPQTVQ	MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDAERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATAASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYMLTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTIRTLVEQHNIAEAYTLKT	8.31	gnl|BL_ORD_ID|2260|hsp_num:0	2654
NODE_17922_length_677_cov_3.36977_1 # 164 # 676 # 1 # ID=15330_1;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.341	NODE_17922_length_677_cov_3.36977_1 	164	676	+	Strict	400	340.502	ErmB	98.83	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACAAAAATATAAAATATTCTCAAAACTTTTTAACGAGTGAAAAAGTACTCAACCAAATAATAAAACAATTGAATTTAAAAGAAACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAGGTAACGTCTATTGAATTAGACAGTCATCTATTCAACTTATCGTCAGAAAAATTAAAACTGAATACTCGTGTCACTTTAATTCACCAAGATATTCTACAGTTTCAATTCCCTAACAAACAGAGGTATAAAATTGTTGGGAATATTCCTTACCATTTAAGCACACAAATTATTAAAAAAGTGGTTTTTGAAAGCCGTGCGTCTGACATCTATCTGATTGTTGAAGAAGGATTCTACAAGCGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAGCAATTGCTTAAGCTGCCAGCGGAATGCTTTCATCCTAAACCAAAAGTAAACAGTGTC	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSV	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	68.95	gnl|BL_ORD_ID|1477|hsp_num:0	1549
NODE_18315_length_667_cov_2.05882_1 # 2 # 181 # -1 # ID=15607_1;partial=10;start_type=ATG;rbs_motif=TATAA;rbs_spacer=15bp;gc_cont=0.450	NODE_18315_length_667_cov_2.05882_1 	2	181	-	Strict	550	21.557	KPC-13	100.0	3002323	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGTCCTTATTTGCACCAGAGGAAGAAAAAACGCTGTCTTTTGATGAATATATGGCCTCGTTTGATGCGAATCGGGTAGCAAAAGTACAGCAGTTTGTAGACTGGCTCGGTCAATATAGAGGCGAGCTTGTTCACAATCCGTGGGGTGAGGTGAATTCCGACCTCGAAATTGTTCGGTCT	MSLFAPEEEKTLSFDEYMASFDANRVAKVQQFVDWLGQYRGELVHNPWGEVNSDLEIVRS	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLGTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ	20.48	gnl|BL_ORD_ID|1771|hsp_num:0	1851
NODE_18509_length_662_cov_3.49423_1 # 1 # 102 # -1 # ID=15737_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.471	NODE_18509_length_662_cov_3.49423_1 	1	102	-	Strict	500	19.2458	Vibrio cholerae varG	100.0	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	subclass B1 Vibrio cholerae varG beta-lactamase	ATGGGTTTTTTTAAAAAGGTTTTTGGTGGCGGCGGTGGCGGTAGTGGACATACGCCTGTTGAAGCAAAAGAAAGCGGACGTAGCAAACAGCGAGTCAAAATC	MGFFKKVFGGGGGGSGHTPVEAKESGRSKQRVKI	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	8.72	gnl|BL_ORD_ID|2341|hsp_num:0	2842
NODE_19719_length_637_cov_3.42612_1 # 2 # 637 # 1 # ID=16521_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.431	NODE_19719_length_637_cov_3.42612_1 	2	637	+	Strict	1200	443.351	tetQ	100.0	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GATTTTCGAATCGGAGATTATTTAGGTACTAAACCTTGTTTGATTCAAGGGTTATCTCATCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAGACAGGTCCGAAGAGAGAAGCAAGGTGATATCCGCTCTGAATACATTGTGGATTGAAGACCCGTCTTTGTCCTTTTCCATAAACTCATATAGTGATGAATTGGAAATCTCGTTATATGGTTTGACACAAAAGGAAATCATACAGACATTGCTGGAAGAACGATTTTCCGTAAAGGTCCATTTTGATGAGATCAAGACTATCTACAAAGAACGACCTGTAAAAAAGGTCAATAAGATTATTCAGATCGAAGTGCCACCCAACCCTTACTGGGCCACAATAGGGCTGACGCTTGAACCCTTGCCGTTAGGGACAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCTGGTTTACATGGATGGGAAGTGACAGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCCTTGCAACAGTCAGGTGTG	DFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGV	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	32.27	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_20927_length_612_cov_4.62657_1 # 2 # 136 # 1 # ID=17314_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.444	NODE_20927_length_612_cov_4.62657_1 	2	136	+	Strict	550	87.4261	RlmA(II)	95.45	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATCACAGCAGATCAGCTCCAAGCCCTACTCAGTATGACCCCTCTACTCTTTCACGTTGATCAGACTAAGATTGACTGGAGCCAACTGACAGAGATTACTATTGAGGCAGAGATACTTGTTGGGAAAGCATTCTAA	ITADQLQALLSMTPLLFHVDQTKIDWSQLTEITIEAEILVGKAF	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	15.60	gnl|BL_ORD_ID|2126|hsp_num:0	2274
NODE_24035_length_560_cov_3.73069_1 # 380 # 559 # -1 # ID=19168_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.561	NODE_24035_length_560_cov_3.73069_1 	380	559	-	Strict	500	21.9422	mphC	100.0	3000319	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	TTCTTAGCCGAAGCTGCGGCCGAATCTGAAGCTCTCCAACGTCCCCTACCACAGGATGACGAAGGGCTCGAGCAGCTGATCCGTGACCTCTTCCAGAGTAGTGACCCCTACTTCACGCCCTCTGGCAAACCCATCATCACGCGCCTCACGGAGCCAATGGTTGCCAACTTCTTCAACTAA	FLAEAAAESEALQRPLPQDDEGLEQLIRDLFQSSDPYFTPSGKPIITRLTEPMVANFFN	MTQHNEIIKIAEKHQLHIKPQTISLNESGLDFQVAFGEDEHGIEWVLRLPRRPDVYKRTKPEKQMVDFLQKNVSFEVPNWKVHTKDLIAYPKLTGKPAATIDPEIQNYVWEIEHKPVTKNFINTLAETLVDLHNIPEENITAHHINIKTIQEIKNDFQRRMNKVRETYGVADGLWNRWKQWLENDELWPRRATMIHGDLHPGHIMVDNQANVTGLIDWTEATYSDPSMDFMGYHRVFDDEGLEQLITAYDKAGGETWPRMKEHIIELNAVFPMFIAEFAMESGEPAYEKMALQELGMKE	19.73	gnl|BL_ORD_ID|1972|hsp_num:0	2062
NODE_27672_length_512_cov_2.52735_1 # 2 # 100 # 1 # ID=21143_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.333	NODE_27672_length_512_cov_2.52735_1 	2	100	+	Strict	350	19.631	cat	100.0	3002670	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATAGAATGTGGTTCTTGTGCTTATATTTGTCCTGCTAATAGACCTTTAGCTGAGGCTATTAAAACAGGAAAAGCTAAATTAAGAGCTAAGAAAAAGTAG	IECGSCAYICPANRPLAEAIKTGKAKLRAKKK	MEFRLVDLKTWKRKEYFTHYFESVPCTYSMTVKLDITTIKTGKAKLYPALLYAVSTVVNRHEEFRMTVDDEGQIGIFSEMMPCYTIFQKDTEMFSNIWTEYIGDYTEFCKQYEKDMQQYGENKGMMAKPNPPVNTFPVSMIPWTTFEGFNLNLQKGYGYLLPIFTFGRYYEENGKYWIPLSIQVHHAVCDGFHTCRFINELQDVIQSLQNHGGDEE	14.81	gnl|BL_ORD_ID|792|hsp_num:0	823
